Skip to main content

Table 3 Main outcomes measures, for total calculation and subgroups

From: Antibiotic prophylaxis for prevention against Lyme disease following tick bite: an updated systematic review and meta-analysis

  Studies (n) Participants (n) Rate in intervention (%) I2 (%) Participants (n) Rate in control (%) I2 (%) Risk ratio I2 (%)
Oral treatment 5 1584 0.2 (0.0–1.0) 57 1187 2.5 (1.7–3.5) 0 0.29 (0.15–0.57) 0
10-day course 3 308 0.0 (0.0–0.3) 0 292 1.3 (0.3–2.9) 0 0.28 (0.05–1.67) 0
Single dose 2 1276 0.8 (0.4–1.4) 0 895 3.0 (2.0–4.2) 0 0.29 (0.14–0.60) 0
Topical treatment 1 505 1.2 (0.4–2.3) N/A 490 1.6 (0.7–2.9) N/A 0.73 (0.25–2.08) N/A
Total 6 2089 0.4 (0.1–1.1) 55 1677 2.2 (1.6–3.0) 5 0.38 (0.22–0.66) 0